Abpro Holdings Inc. (ABPO) vs NexImmune, Inc. (NEXI)
Abpro Holdings Inc. and NexImmune, Inc. are both Biotechnology companies. NexImmune, Inc. is the larger, with a market value of $1.6M against $1.4M — 1.1× the size. NexImmune, Inc. has negative trailing earnings, so its P/E is not meaningful; Abpro Holdings Inc. trades at 0.2×. Across the 8 metrics below, Abpro Holdings Inc. leads on 5 and NexImmune, Inc. on 3.
Valuation
Profitability
| Metric | ABPO | NEXI | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (20.18%) | (232.97%) | (57.72%) |
| Return on assets | 46.10% | (140.56%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack